U.S. stock futures were lower this morning, with the Dow futures falling more than 300 points on Monday.
Shares ofExelixis Inc(NASDAQ:EXEL) fell sharply in pre-market trading after the company announced preliminary fiscal year 2025 financial results.
Exelixis reported preliminary 2025 US net product revenue of $2.123 billion. The company also said it sees 2026 net product revenue of $2.325 billion to $2.425 billion.
Exelixis shares dipped 4.6% to $42.01 in pre-market trading.
Here are some other stocks moving lower in pre-market trading.
- Synchrony Financial(NYSE:SYF) dipped 9.5% to $78.61 in pre-market trading.
- Stoke Therapeutics Inc (NASDAQ:STOK) declined 8.7% to $30.00 in pre-market...
Login or create a forever free account to read this news
Sign up/Log in